Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Oct. 31, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for ...

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jun. 28, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, ...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on October 31, 2024 that were ...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

CAMBRIDGE, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, ...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

CAMBRIDGE, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, ...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

CAMBRIDGE, Mass. , May 31, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, ...

Sarepta Therapeutics Announces Inducement Grant Under Nasdaq ...

Sarepta Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4). News Provided By. GlobeNewswire. April 05, 2017, 21:00 ...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

28, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June ...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

The options have an exercise price of $115.96 per share, which is equal to the closing price of Sarepta's common stock on January 31, 2020 (the “Grant Date”).

Esperion Announces Inducement Grant Under NASDAQ Listing ...

Esperion Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) ... ANN ARBOR, Mich., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ ...

Press Releases | Sarepta Therapeutics, Inc. - Investor Relations

Press Releases ; 10/23/24, Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results ; 9/30/24, Sarepta Therapeutics Announces Inducement Grants Under ...

"Inducement" headlines - NewsNow

Couchbase Announces New Employee Inducement Grants PR Newswire (Press Release) 13:31 Fri, 30 Aug. Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

Sarepta Stock Price Today | NASDAQ: SRPT Live - Investing.com

View today's Sarepta Therapeutics Inc stock price and latest SRPT news and analysis. Create real-time notifications to follow any changes in the live stock ...

COMMUNIQUÉS West-GlobeNewswire | Page 2326 - Santé log

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). 01/02/2018 - 00:30. CAMBRIDGE, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) ...

BCRX Stock Price - BioCryst Pharmaceuticals Inc. - MarketWatch

BioCryst announces ORLADEYO approval in Peru. Jul. 9, 2024 at 7:03 a.m. ET on TipRanks.com. BioCryst reports inducement grants under Nasdaq listing rule. Jul ...

Tempest Reports Inducement Grant Under Nasdaq Listing Rule ...

... in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company's Board ...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq ...

30, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on April ...

Energy Vault Holdings, Inc. Announces Inducement Grants Under ...

r/Quantisnow - Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c. quantisnow. 1 upvote. r/Shortsqueeze icon. r ...

Positive Outlook for Cartesian Therapeutics: Buy Rating Driven by ...

The company recently achieved favorable topline results from a Phase IIb study, which showcased the potential of their product, Descartes-08.